{"id":72469,"date":"2023-08-21T23:41:21","date_gmt":"2023-08-21T18:11:21","guid":{"rendered":"http:\/\/finservwealth.com\/shiva-pharmachem-files-draft-papers-to-raise-rs-900-crore-via-ipo\/"},"modified":"2023-08-21T23:41:21","modified_gmt":"2023-08-21T18:11:21","slug":"shiva-pharmachem-files-draft-papers-to-raise-rs-900-crore-via-ipo","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/shiva-pharmachem-files-draft-papers-to-raise-rs-900-crore-via-ipo\/","title":{"rendered":"Shiva Pharmachem files draft papers to raise Rs 900 crore via IPO"},"content":{"rendered":"<p> Shiva Pharmachem is planning to mop up Rs 900 crore via public issue which comprises only an offer for sale by its promoters<\/p><div id=\"finse-3132176876\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/shiva-pharmachem-files-draft-papers-to-raise-rs-900-crore-via-ipo_17213761.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Shiva Pharmachem is planning to mop up Rs 900 crore via public issue which comprises only an offer for sale by its promoters Shiva Pharmachem is planning to mop up Rs 900 crore via public issue which comprises only an offer for sale by its promoters\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/shiva-pharmachem-files-draft-papers-to-raise-rs-900-crore-via-ipo_17213761.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Shiva Pharmachem is planning to mop up Rs 900 crore via public issue which comprises only an offer for sale by its promoters<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/shiva-pharmachem-files-draft-papers-to-raise-rs-900-crore-via-ipo_17213761.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Shiva Pharmachem is planning to mop up Rs 900 crore via public issue which comprises only an offer for sale by its promoters Shiva Pharmachem is planning to mop up Rs 900 crore via public issue which comprises only an offer for sale by its promoters\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/shiva-pharmachem-files-draft-papers-to-raise-rs-900-crore-via-ipo_17213761.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Shiva Pharmachem is planning to mop up Rs 900 crore via public issue which comprises only an offer for sale by its promoters<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-72469","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2023\/200x200\/C\/Chemicals_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/72469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=72469"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/72469\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=72469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=72469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=72469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}